SAN DIEGO--(BUSINESS WIRE)--In 2021, XIFIN took significant steps to expand its support for customers nationwide through entry into new markets and regions, and ongoing innovation of its award-winning revenue cycle management (RCM) and laboratory information system (LIS) solutions. As a result of these accomplishments, XIFIN is positioned to open up a new “front door” to diagnostic providers – facilitating communication and data exchange through the retail pharmacy ecosystem, driving even greater patient access to healthcare information.

Also in 2021, as a result of its commitment to customers, XIFIN was ranked #1 for Laboratory Support and RCM by Black Book Research for the second consecutive year. It was also named to the Inc. 5000 List of Fastest-Growing Private Companies in America for a 12th time, reflecting a 60% growth in revenue in just three years. Additionally, the company continued to act as a source of valuable insights about COVID-19 testing trends in the U.S. through its Lab Volume Index.

“As we head towards our 25th year in operations, we’re proud to provide valuable support and innovative solutions to labs and other types of diagnostic providers, hospitals, pharmacies, and specialty physician groups as they continue to face the overriding demands caused by the Coronavirus pandemic,” said Lâle White, executive chair and CEO at XIFIN. “We’re witnessing the increasing consumerization of healthcare and our strong market presence in existing and new segments will ultimately bring together complementary clinical and financial information for our customers, helping them efficiently care for patients and manage their business.”
Company Expands Markets and Footprint to Address Evolving Industry Trends

During 2021, XIFIN expanded its operations to Charleston, S.C., and acquired two companies in complimentary healthcare market segments, growing its staff to nearly 800 employees, a 54% increase in company size. Establishing operations in South Carolina solidified an East Coast presence for the West Coast-based company and will create more than 150 new jobs over the next two years.

XIFIN also entered the radiology and retail pharmacy segments through strategic acquisitions, solidifying its role as a top provider of solutions and services that streamline and optimize the billing and claims process, provide healthcare leaders with greater business visibility, and support patient engagement. The company most recently acquired OmniSYS, a leading provider of technology solutions for the retail pharmacy industry serving four of the top five national chains. This past year, OmniSYS has achieved several notable accomplishments:

Business Affairs Homepage